Emily C. Liang, MD
Assistant Professor
Clinical Research Division, Fred Hutch
Dr. Emily Liang is a board-certified hematologist-oncologist whose research focuses on clinical and translational research in cellular therapies and statistical modeling of treatment outcomes. She received a Young Investigator Award from the American Society of Clinical Oncology and the Hartwell Innovation Fund from Swim Across America in 2024.
Other Appointments & Affiliations
Physician, Fred HutchPhysician
Fred Hutch
Assistant Professor
Division of Hematology and Oncology, University of Washington School of Medicine
Education
Fellowship, Hematology and Oncology, Fred Hutch/University of Washington, 2025
Residency, Internal Medicine, Stanford University, 2022
MD, David Geffen School of Medicine at UCLA, 2019
BA, Human Biology, Stanford University, 2014
Research Focus
Clinical and translational research in cellular therapies
Clinical trials
Outcomes research
Statistical modeling of treatment outcomes
Clinical Expertise
Blood and marrow transplantation
Immunotherapy
Board Certification
Hematology, 2025; Medical Oncology, 2025; Internal Medicine, 2022; American Board of Internal Medicine